CloudCharts5 days agoIOVA - $110 all-time high...? The stock is extremely undervalued with the recent FDA approval of its skin cancer therapy which from what I've read cost $500k per treatment. - Strong Buy
CloudChartsMar 27IOVA - Expanding operations/manufacturing = a spike in demand coming.European approval is coming.The stock is dirt cheap.philadelphia.today/2025/03/iovance-biotherapeutics-new-jobs/?s=09
magiclydonkeyFeb 13IOVA 300,000 warrants is spewy for a company that is losing money and stock has been severely dilluted. The optics are as bad as the investment.
LongTermHoldMar 8, 2024IOVA yea ceo bought 45 mil worth of stock last month. That’s a big no play number even if you are a rich guy